Drug recall · August 14, 2024
Gabapentin Tablets recall
Why: Presence of Foreign Tablets; 3 fused tablets of Metformin ER 500 mg were found in bottle of Gabapentin Tablets
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Gabapentin Tablets, USP, 600 mg, 500-count bottles, Rx only, Manufactured by: Granules India Limited Hyderabad-500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA NDC 70010-227-05
- Lots / codes
Lot 1380040A, Exp. date July 31, 2025
- Quantity
- 11,808 500-count Bottles
- Company
- Granules Pharmaceuticals Inc., Chantilly, VA
- Distribution
- Nationwide in the USA
- Initiated
- July 31, 2024 · Voluntary: Firm initiated
- Classified
- August 14, 2024
- Reported
- August 14, 2024
- Ended
- June 12, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Gabapentin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.